Home

USANA Health Sciences Reports Second Quarter 2025 Results and Reiterates Full-Year Outlook

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended June 28, 2025.

Key Financial Results

Second Quarter 2025 vs. Second Quarter 2024

  • Net sales of $236 million versus $213 million, representing 11% year-over-year growth.
  • Net earnings of $9.7 million versus $10.4 million.
  • Diluted EPS of $0.52 as compared with $0.54.
  • Adjusted diluted EPS(1) of $0.74 as compared with $0.54.
  • Adjusted EBITDA(2) of $30 million versus $27 million.
  • Direct selling Active Customers of 418,000 versus 468,000.
  • Hiya Active Monthly Subscribers of 200,400.
  • Company reiterates fiscal year 2025 outlook.

Q2 2025 Financial Performance

Consolidated Results

 

Year-Over-Year

Sequentially

Net Sales

$236 million

+11% (No meaningful FX impact)

-5%

Net Earnings

$9.7 million

-7%

+3%

Diluted EPS

$0.52

-4%

+6%

Adjusted Diluted EPS(1)

$0.74

+36%

+1%

Adjusted EBITDA(2)

$30.5 million

+13%

+2%

Net earnings, EPS and EBITDA figures represent amounts attributable to USANA and excludes the noncontrolling interest of 21.15% in Hiya

“USANA delivered positive second quarter results, highlighted by 11% year-over-year consolidated net sales growth,” said Jim Brown, President and Chief Executive Officer. “Our business performed in line with expectations, and we are maintaining our fiscal 2025 outlook.

Mr. Brown also reported: “We continue to execute our comprehensive commercial strategy for our direct sales business, which represents over two years of research, analysis, and planning. During the quarter, we made several important announcements to advance this strategy, including preliminary communications about the enhanced incentive offering we are currently rolling out to our sales force, as well as our adoption of 'Brand Partner' as the terminology we will use to describe members of our direct sales business. We will make other important announcements to advance this strategy at our global convention in August (Salt Lake City, Utah), and throughout the third quarter, including the simplification of our direct sales model, additional enhanced sales incentives, improved personalized business support for our Brand Partners, refreshed USANA brand messaging, and several new and enhanced health products. The continued roll-out of this commercial strategy is intended to provide our Brand Partners with a more compelling opportunity to drive sustainable sales and Active Customer growth.

“Hiya, our direct-to-consumer business, had another strong quarter as year-over-year top line growth remained strong with improved profitability. Sequential sales and Active Monthly Subscriber trends were consistent with expectations, reflecting normal seasonality in this business. Notably, the Hiya team recently launched a new partnership with Disney which includes special edition Disney Lion King and Disney Princesses branded Multivitamin packs. Overall, we remain confident in the growth outlook of this business as the Hiya team continues to execute its strategies to further expand its product offering, distribution channels and geographic footprint.”

Q2 2025 Direct Selling Regional Results:

Asia Pacific Region

 

 

Year-Over-Year

Year-Over-Year

(Constant Currency)

Sequentially

Net Sales

$163 million

-4%

-5%

-6%

Active Customers

336,000

-9%

N/A

-10%

Asia Pacific Sub-Regions

 

 

 

Year-Over-Year

Year-Over-Year

(Constant Currency)

Sequentially

Greater China

Net Sales

$113 million

-2%

No meaningful FX impact

-5%

Active

231,000

-8%

N/A

-9%

Customers

North Asia

Net Sales

$17 million

-13%

-11%

-9%

Active

37,000

-12%

N/A

-18%

Customers

Southeast Asia Pacific

Net Sales

$33 million

-7%

-10%

-8%

Active

68,000

-12%

N/A

-9%

Customers

Americas and Europe Region

 

 

Year-Over-Year

Year-Over-Year

(Constant Currency)

Sequentially

Net Sales

$39 million

-8%

-7%

-1%

Active Customers

82,000

-17%

N/A

-4%

Q2 2025 Hiya Direct to Consumer Results:

Hiya

Net Sales

$34 million

Active Monthly Subscribers

200,400

Balance Sheet and Share Repurchase Activity

During the second quarter, the Company generated $13 million in operating cash flow and ended the quarter with $151 million in cash and cash equivalents and zero debt. The Company repurchased 528,000 shares during the second quarter for an investment of $15 million with approximately $34 million remaining under the current share repurchase authorization as of the end of the second quarter.

Fiscal Year 2025 Outlook

The Company is reiterating its outlook for fiscal year 2025, as follows:

Fiscal Year 2025 Outlook

 

Range

Consolidated net sales

$920 million to $1.0 billion

Net earnings

$29 million to $41 million

Diluted EPS

$1.50 to $2.20

Adjusted Diluted EPS(1)

$2.35 to $3.00

Adjusted EBITDA(2)

$107 million to $123 million

Net earnings, EPS and EBITDA figures represent amounts attributable to USANA and excludes the noncontrolling interest of 21.15% in Hiya

“Second quarter operating results for both our core direct sales business and for Hiya were in line with internal expectations as we continued to execute our overall growth strategy,” said Doug Hekking, Chief Financial Officer. “During the quarter, we also repaid the $23 million draw on our credit facility deployed in the Hiya transaction and are again debt-free.

“We are reiterating our fiscal 2025 outlook and continue to anticipate consolidated net sales growth of 8% to 17%. The wider than normal range reflects the fluid operating environment and changes to our direct sales incentive offering. During the third quarter we anticipate a short-term increase in promotional costs in conjunction with the global launch of our enhanced direct sales compensation plan. Additionally, we anticipate increased spending on customer acquisition sequentially in our Hiya business during the third quarter, which reflects normal seasonal activity.”

The Company’s fiscal 2025 outlook reflects:

  • Net sales from the direct selling business of $775 to $840 million;
  • Net sales from Hiya of $145 to $160 million, reflecting year-over-year growth of +29% to +42%;
  • Effective tax rate of 44.0% to 45.0%; and
  • Fiscal 2025 is a 53-week year and includes one additional week of sales compared to fiscal 2024. Prior to 2025, the last 53-week year was in fiscal 2020.
   

(1)

Adjusted Diluted Earnings Per Share is a non-GAAP financial measure. The Company excludes acquisition-related costs, such as business transaction costs, integration expense and amortization expense from acquisition related intangible assets in calculating Adjusted Diluted Earnings Per Share. Please refer to “Non-GAAP Financial Measures” and “Reconciliation of Diluted Earnings Per Share (GAAP) to Adjusted Diluted Earnings Per Share (Non-GAAP)” in this press release for an explanation and reconciliation of this non-GAAP financial measure.

(2)

Adjusted EBITDA is a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” and “Reconciliation of Net Earnings (GAAP) to Adjusted EBITDA (Non-GAAP)” in this press release for an explanation and reconciliation of this non-GAAP financial measure.

Non-GAAP Financial Measures

This press release contains the non-GAAP financial measures Adjusted EBITDA and Adjusted diluted EPS. Adjusted EBITDA is a Non-GAAP financial measure of earnings before interest, taxes, depreciation, and amortization that also excludes certain adjustments as indicated below in the reconciliation from net earnings. Adjusted diluted EPS is a Non-GAAP financial measure of diluted earnings per share that excludes certain adjustments as indicated below in the reconciliation from diluted EPS.

Adjusted EBITDA (non-GAAP) is net earnings (loss) (its most directly comparable GAAP financial measure) adjusted for interest expense, net, (benefit from) provision for income taxes, depreciation and amortization, non-cash share-based compensation, and transaction-related expenses and integration costs for the Hiya acquisition. Adjusted EBITDA attributable to USANA (non-GAAP) is Adjusted EBITDA (non-GAAP) further adjusted to exclude the Adjusted EBITDA attributable to non-controlling interest related to Hiya.

Adjusted diluted earnings per share (non-GAAP) is diluted earnings (loss) per share (its most directly comparable GAAP financial measure) adjusted for amortization of intangible assets, transaction-related expenses, and integration costs related to the Hiya acquisition.

Management believes that Adjusted EBITDA (non-GAAP), Adjusted EBITDA attributable to USANA (non-GAAP), and Adjusted diluted earnings per share (non-GAAP), along with GAAP measures used by management, most appropriately reflect how the Company measures the business internally.

The Company prepares its financial statements using U.S. generally accepted accounting principles (“GAAP”) and investors should not directly compare with or infer relationship from any of the Company’s operating results presented in accordance with GAAP to Adjusted EBITDA and Adjusted diluted earnings per share. Non-GAAP financial measures have limitations in their usefulness to investors because they have no standardized meaning prescribed by GAAP and are not prepared under any comprehensive set of accounting rules or principles. In addition, other companies, including companies in our industry, may calculate similarly titled non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of non-GAAP financial information as a tool for comparison. As a result, the non-GAAP financial information is presented for supplemental informational purposes only and should not be considered in isolation from, or as a substitute for financial information presented in accordance with GAAP.

Reconciliation of Net Earnings (GAAP) to Adjusted EBITDA (non-GAAP)

(in thousands)

 

 

 

Quarter Ended

 

Six Months Ended

 

 

June 28, 2025

 

June 29, 2024

 

June 28, 2025

 

June 29, 2024

 

 

 

 

 

 

 

 

 

Net earnings attributable to USANA (GAAP)

 

$

9,655

 

 

$

10,432

 

 

$

19,057

 

 

$

26,969

 

Net earnings attributable to noncontrolling interest

 

 

789

 

 

 

 

 

 

677

 

 

 

 

Net earnings

 

$

10,444

 

 

$

10,432

 

 

$

19,734

 

 

$

26,969

 

 

 

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

 

 

Income taxes

 

$

8,373

 

 

$

9,771

 

 

$

15,822

 

 

$

20,345

 

Interest (income) expense

 

 

(360

)

 

 

(2,712

)

 

 

(672

)

 

 

(5,336

)

Depreciation and amortization

 

 

5,148

 

 

 

5,702

 

 

 

10,938

 

 

 

10,786

 

Amortization of intangible assets - Hiya

 

 

4,456

 

 

 

 

 

 

8,911

 

 

 

 

Earnings before interest, taxes, depreciation, and amortization (EBITDA)

 

$

28,061

 

 

$

23,193

 

 

$

54,733

 

 

$

52,764

 

 

 

 

 

 

 

 

 

 

Add EBITDA adjustments:

 

 

 

 

 

 

 

 

Non-cash share-based compensation

 

 

3,622

 

 

 

3,734

 

 

 

6,502

 

 

 

7,403

 

Transaction, integration and transition costs - Hiya

 

 

115

 

 

 

 

 

 

692

 

 

 

 

Inventory step-up - Hiya

 

 

544

 

 

 

 

 

 

1,126

 

 

 

 

Consolidated adjusted EBITDA

 

 

32,342

 

 

 

26,927

 

 

 

63,053

 

 

 

60,167

 

Less: Adjusted EBITDA attributable to noncontrolling interest

 

 

(1,847

)

 

 

 

 

 

(2,801

)

 

 

 

Adjusted EBITDA attributable to USANA

 

$

30,495

 

 

$

26,927

 

 

$

60,252

 

 

$

60,167

 

 

Reconciliation of Diluted Earnings Per Share (GAAP) to Adjusted Diluted Earnings Per Share (non-GAAP)

(in thousands, except per share data)

 

 

 

Quarter Ended

 

Six Months Ended

 

 

June 28, 2025

 

June 29, 2024

 

June 28, 2025

 

June 29, 2024

Net earnings attributable to USANA (GAAP)

 

$

9,655

 

 

$

10,432

 

$

19,057

 

 

$

26,969

 

 

 

 

 

 

 

 

 

Earnings per common share - Diluted (GAAP)

 

$

0.52

 

 

$

0.54

 

$

1.01

 

 

$

1.40

Weighted Average common shares outstanding - Diluted

 

 

18,536

 

 

 

19,159

 

 

18,811

 

 

 

19,230

 

 

 

 

 

 

 

 

 

Adjustment to net earnings:

 

 

 

 

 

 

 

 

Transaction, integration and transition costs - Hiya

 

$

115.00

 

 

$

 

$

692.00

 

 

$

Inventory step-up - Hiya

 

 

544

 

 

 

 

 

1,126

 

 

 

Amortization of intangible assets - Hiya

 

 

4,456

 

 

 

 

 

8,911

 

 

 

Adjustments to net earnings attributable to noncontrolling interest

 

 

(1,057

)

 

 

 

 

(2,123

)

 

 

Income tax effect of adjustments to net earnings

 

 

 

 

 

 

 

(4

)

 

 

Adjusted net earnings attributable to USANA

 

$

13,713

 

 

$

10,432

 

$

27,659

 

 

$

26,969

 

 

 

 

 

 

 

 

 

Adjusted earnings per common share - Diluted

 

$

0.74

 

 

$

0.54

 

$

1.47

 

 

$

1.40

Weighted average common shares outstanding - Diluted

 

 

18,536

 

 

 

19,159

 

 

18,811

 

 

 

19,230

Management Commentary Document and Conference Call

For further information on the USANA’s operating results, please see the Management Commentary document, which has been posted on the Company’s website (http://ir.usana.com) under the Investor Relations section. USANA’s management team will hold a conference call and webcast to discuss today’s announcement with investors on Wednesday, July 23, 2025 at 11:00 AM Eastern Time. Investors may listen to the call by accessing USANA’s website at http://ir.usana.com. The call will consist of brief opening remarks by the Company’s management team, followed by a questions and answers session.

Safe Harbor

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. These forward-looking statements are based on current plans, expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management. Words such as “expect,” “enhance,” “drive,” “anticipate,” “intend,” “improve,” “promote,” “should,” “believe,” “continue,” “plan,” “goal,” “opportunity,” “estimate,” “predict,” “may,” “will,” “could,” and “would,” and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Such forward-looking statements include, but are not limited to, statements regarding Hiya’s strong growth in 2025 and continued growth in the future; statements about the Company’s long-term growth; and the statements under the sub-heading “Fiscal Year 2025 Outlook.” Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control, including: risks relating to global economic conditions generally, including continued inflationary pressure around the world and negative impact on our operating costs, consumer demand and consumer behavior in general; reliance upon our network of independent Brand Partners; risk that our Brand Partner compensation plan, or changes that we make to the compensation plan, will not produce desired results, benefit our business or, in some cases, could harm our business; risk associated with our launch of new products or reformulated existing products; risks related to governmental regulation of our products, manufacturing and direct selling business model in the United States, China and other key markets; potential negative effects of deteriorating foreign and/or trade relations between or among the United States, China and other key markets, including potential adverse impact from tariffs, trade policies or other international disputes by and among the United States, China, or other markets that are important to the Company; potential negative effects from geopolitical relations and conflicts around the world, including the Russia-Ukraine conflict and the conflict in Israel; compliance with data privacy and security laws and regulations in our markets around the world; potential negative effects of material breaches of our information technology systems to the extent we experience a material breach; material failures of our information technology systems; adverse publicity risks globally; risks associated with early stage operations in India and future international expansion and operations; uncertainty relating to the fluctuation in U.S. and other international currencies; the potential for a resurgence of COVID-19, or another pandemic, in any of our markets in the future and any related impact on consumer health, domestic and world economies, including any negative impact on discretionary spending, consumer demand, and consumer behavior in general; risk that the Hiya acquisition disrupts each company’s current plans and operations; the diversion of the attention of the management teams of USANA and Hiya from ongoing business operations; the ability of to retain key personnel of Hiya; the ability to realize the benefits of the acquisition, including efficiencies and cost synergies; the ability to successfully integrate Hiya’s business with USANA’s business, at all or in a timely manner; and the amount of the costs, fees, expenses and charges related to the acquisition. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission. The forward-looking statements in this press release set forth our beliefs as of the date hereof. We do not undertake any obligation to update any forward-looking statement after the date hereof or to conform such statements to actual results or changes in the Company’s expectations, except as required by law.

About USANA

USANA develops and manufactures high-quality nutritional supplements, functional foods and personal care products that are sold directly to Brand Partners and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, China, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France, Belgium, Colombia, Indonesia, Germany, Spain, Romania, Italy, and India. More information on USANA can be found at www.usana.com. USANA also owns a 78.8% controlling ownership stake in Hiya Health Products, a children's health and wellness company with a variety of clean-label products. More information on Hiya can be found at www.hiyahealth.com.

 

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

 

Quarter Ended

 

June 28,

2025

 

June 29,

2024

Net sales

$

235,848

 

 

$

212,869

 

Cost of sales

 

50,184

 

 

 

40,333

 

Gross profit

 

185,664

 

 

 

172,536

 

Operating expenses:

 

 

 

Brand Partner incentives

 

87,040

 

 

 

90,371

 

Selling, general and administrative

 

81,906

 

 

 

64,325

 

Total operating expenses

 

168,946

 

 

 

154,696

 

Earnings from operations

 

16,718

 

 

 

17,840

 

Other income (expense):

 

 

 

Interest income

 

619

 

 

 

2,763

 

Interest expense

 

(259

)

 

 

(51

)

Other, net

 

1,739

 

 

 

(349

)

Other income (expense), net

 

2,099

 

 

 

2,363

 

Earnings before income taxes

 

18,817

 

 

 

20,203

 

Income taxes

 

8,373

 

 

 

9,771

 

Net earnings

 

10,444

 

 

 

10,432

 

Less: Net earnings (loss) attributable to redeemable noncontrolling interest

 

789

 

 

 

 

Net earnings attributable to USANA

$

9,655

 

 

$

10,432

 

 

 

 

 

Earnings per common share attributable to USANA

 

 

 

Basic

$

0.52

 

 

$

0.55

 

Diluted

$

0.52

 

 

$

0.54

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

Basic

 

18,513

 

 

 

19,073

 

Diluted

 

18,536

 

 

 

19,159

 

 

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

 

 

As of

June 28,

2025

 

As of

December 28,

2024

ASSETS

 

 

 

Current assets

 

 

 

Cash and cash equivalents

$

151,338

 

$

181,768

Inventories

 

83,269

 

 

69,735

Prepaid expenses and other current assets

 

27,259

 

 

27,684

Total current assets

 

261,866

 

 

279,187

Property and equipment, net

 

96,532

 

 

94,565

Goodwill

 

144,230

 

 

144,168

Intangible assets, net

 

142,747

 

 

151,823

Deferred tax assets

 

26,435

 

 

19,644

Other assets*

 

62,716

 

 

58,806

Total assets

$

734,526

 

$

748,193

 

 

 

 

LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST, AND STOCKHOLDERS' EQUITY

 

 

 

Current liabilities

 

 

 

Accounts payable

$

17,899

 

$

11,984

Line of credit

 

 

 

23,000

Other current liabilities

 

103,726

 

 

104,641

Total current liabilities

 

121,625

 

 

139,625

Deferred tax liabilities

 

4,662

 

 

4,073

Other long-term liabilities

 

22,681

 

 

18,163

 

 

 

 

Redeemable noncontrolling interest

 

54,498

 

 

54,223

 

 

 

 

Stockholders' equity attributable to USANA

 

531,060

 

 

532,109

Total liabilities, redeemable noncontrolling interest, and stockholders' equity

$

734,526

 

$

748,193

 

*Includes noncurrent inventories of $2,976 and $2,688 as of 28-Jun-25 and 28-Dec-24, respectively. Total inventories were $86,245 and $72,423 as of 28-Jun-25 and 28-Dec-24, respectively.

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

SALES BY REGION

(in thousands)

(unaudited)

 

 

Quarter Ended

 

 

 

 

 

 

 

 

 

June 28,

2025

 

June 29,

2024

 

Change from prior

year

 

Percent change

 

Currency impact on

sales

 

Percent change

excluding currency

impact

Direct Selling:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia Pacific

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater China

$

113,171

 

48.0

%

 

$

115,513

 

54.3

%

 

$

(2,342

)

 

(2.0

%)

 

$

(14

)

 

(2.0

%)

Southeast Asia Pacific

 

32,887

 

13.9

%

 

 

35,402

 

16.6

%

 

 

(2,515

)

 

(7.1

%)

 

 

1,083

 

 

(10.2

%)

North Asia

 

17,166

 

7.3

%

 

 

19,710

 

9.3

%

 

 

(2,544

)

 

(12.9

%)

 

 

(342

)

 

(11.2

%)

Asia Pacific total

 

163,224

 

69.2

%

 

 

170,625

 

80.2

%

 

 

(7,401

)

 

(4.3

%)

 

 

727

 

 

(4.8

%)

Americas and Europe

 

35,904

 

15.2

%

 

 

40,583

 

19.0

%

 

 

(4,679

)

 

(11.5

%)

 

 

(699

)

 

(9.8

%)

Direct Selling total

 

199,128

 

84.4

%

 

 

211,208

 

99.2

%

 

 

(12,080

)

 

(5.7

%)

 

 

28

 

 

(5.7

%)

Hiya

 

33,931

 

14.4

%

 

 

 

%

 

 

33,931

 

 

N/A

 

 

 

 

 

N/A

 

Other

 

2,789

 

1.2

%

 

 

1,661

 

0.8

%

 

 

1,128

 

 

67.9

%

 

 

 

 

67.9

%

Consolidated total

$

235,848

 

100.0

%

 

$

212,869

 

100.0

%

 

$

22,979

 

 

10.8

%

 

$

28

 

 

10.8

%

 

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

DIRECT SELLING ACTIVE BRAND PARTNERS AND ACTIVE PREFERRED CUSTOMERS BY REGION

(unaudited)

 

Direct Selling Active Brand Partners by Region(1)

(unaudited)

 

 

As of

June 28, 2025

 

As of

June 29, 2024

Asia Pacific:

 

 

 

 

 

 

 

 

Greater China

 

64,000

 

37.2

%

 

68,000

 

35.2

%

Southeast Asia Pacific

 

45,000

 

26.2

%

 

52,000

 

27.0

%

North Asia

 

26,000

 

15.1

%

 

28,000

 

14.5

%

Asia Pacific Total

 

135,000

 

78.5

%

 

148,000

 

76.7

%

 

 

 

 

 

 

 

 

 

Americas and Europe

 

37,000

 

21.5

%

 

45,000

 

23.3

%

 

 

172,000

 

100.0

%

 

193,000

 

100.0

%

Direct Selling Active Preferred Customers by Region(2)

(unaudited)

 

 

As of

June 28, 2025

 

As of

June 29, 2024

Asia Pacific:

 

 

 

 

 

 

 

 

Greater China

 

167,000

 

67.9

%

 

182,000

 

66.2

%

Southeast Asia Pacific

 

23,000

 

9.3

%

 

25,000

 

9.1

%

North Asia

 

11,000

 

4.5

%

 

14,000

 

5.1

%

Asia Pacific Total

 

201,000

 

81.7

%

 

221,000

 

80.4

%

 

 

 

 

 

 

 

 

 

Americas and Europe

 

45,000

 

18.3

%

 

54,000

 

19.6

%

 

 

246,000

 

100.0

%

 

275,000

 

100.0

%

 
(1) Brand Partners are independent distributors of our products who also purchase our products for their personal use. We only count as active those Brand Partners who have purchased from us any time during the most recent three-month period, either for personal use or resale.
(2) Preferred Customers purchase our products strictly for their personal use and are not permitted to resell or to distribute the products. We only count as active those Preferred Customers who have purchased from us any time during the most recent three-month period. China utilizes a Preferred Customer program that has been implemented specifically for that market.
 

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

OPERATING RESULTS AS A PERCENTAGE OF NET SALES

(unaudited)

 

 

 

Quarter Ended

 

 

June 28, 2025

 

June 29, 2024

 

 

Direct selling & Other

 

Hiya direct-to-consumer

 

Consolidated

 

Direct selling & Other

 

Hiya direct-to-consumer

 

Consolidated

Net sales

 

100.0%

 

100.0%

 

100.0%

 

100.0%

 

N/A

 

100.0%

Cost of sales

 

18.8%

 

36.2%

 

21.3%

 

18.9%

 

N/A

 

18.9%

Gross profit

 

81.2%

 

63.8%

 

78.7%

 

81.1%

 

N/A

 

81.1%

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Brand Partner incentives

 

43.1%

 

—%

 

36.9%

 

42.5%

 

N/A

 

42.5%

Selling, general and administrative

 

31.7%

 

52.8%

 

34.7%

 

30.2%

 

N/A

 

30.2%

Total operating expenses

 

74.8%

 

52.8%

 

71.6%

 

72.7%

 

N/A

 

72.7%

Earnings from operations

 

6.4%

 

11.0%

 

7.1%

 

8.4%

 

N/A

 

8.4%

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of acquired intangible assets

 

0.2%

 

13.1%

 

2.0%

 

0.3%

 

N/A

 

0.3%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

June 28, 2025

 

June 29, 2024

 

 

Direct selling & Other

 

Hiya direct-to-consumer

 

Consolidated

 

Direct selling & Other

 

Hiya direct-to-consumer

 

Consolidated

Net sales

 

100.0%

 

100.0%

 

100.0%

 

100.0%

 

N/A

 

100.0%

Cost of sales

 

18.4%

 

37.2%

 

21.1%

 

18.9%

 

N/A

 

18.9%

Gross profit

 

81.6%

 

62.8%

 

78.9%

 

81.1%

 

N/A

 

81.1%

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Brand Partner incentives

 

42.7%

 

—%

 

36.5%

 

42.2%

 

N/A

 

42.2%

Selling, general and administrative

 

31.8%

 

58.3%

 

35.7%

 

29.2%

 

N/A

 

29.2%

Total operating expenses

 

74.5%

 

58.3%

 

72.2%

 

71.4%

 

N/A

 

71.4%

Earnings from operations

 

7.1%

 

4.5%

 

6.7%

 

9.7%

 

N/A

 

9.7%

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of acquired intangible assets

 

0.1%

 

12.5%

 

2.0%

 

0.2%

 

N/A

 

0.2%

 

Contacts